摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Acetic acid 2-(5-benzo[1,3]dioxol-5-yl-3-benzyloxycarbonylamino-2-oxo-2,3-dihydro-benzo[e][1,4]diazepin-1-yl)-ethyl ester | 645059-93-4

中文名称
——
中文别名
——
英文名称
Acetic acid 2-(5-benzo[1,3]dioxol-5-yl-3-benzyloxycarbonylamino-2-oxo-2,3-dihydro-benzo[e][1,4]diazepin-1-yl)-ethyl ester
英文别名
——
Acetic acid 2-(5-benzo[1,3]dioxol-5-yl-3-benzyloxycarbonylamino-2-oxo-2,3-dihydro-benzo[e][1,4]diazepin-1-yl)-ethyl ester化学式
CAS
645059-93-4
化学式
C28H25N3O7
mdl
——
分子量
515.522
InChiKey
MPRSXACYHHPSNG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

反应信息

  • 作为反应物:
    描述:
    Acetic acid 2-(5-benzo[1,3]dioxol-5-yl-3-benzyloxycarbonylamino-2-oxo-2,3-dihydro-benzo[e][1,4]diazepin-1-yl)-ethyl ester氢溴酸1-羟基苯并三唑溶剂黄1461-(3-二甲基氨基丙基)-3-乙基碳二亚胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 Acetic acid 2-{(R)-5-benzo[1,3]dioxol-5-yl-3-[(S)-3-(3,4-difluoro-phenyl)-2-methyl-propionylamino]-2-oxo-2,3-dihydro-benzo[e][1,4]diazepin-1-yl}-ethyl ester
    参考文献:
    名称:
    High affinity, bioavailable 3-Amino-1,4-benzodiazepine-Based γ-Secretase inhibitors
    摘要:
    In this paper, we describe the development of a novel series of high affinity, orally bioavailable 3-amino-1,4 benzodiazepine-based gamma-secretase inhibitors for the potential treatment of Alzheimer's disease. We disclose structure-activity relationships based around the 1, 3 and 5 positions of the benzodiazepine core structure. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2003.07.031
  • 作为产物:
    描述:
    (5-benzo[1,3]dioxol-5-yl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-carbamic acid benzyl ester 、 alkaline earth salt of/the/ methylsulfuric acid 在 sodium hydride 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 Acetic acid 2-(5-benzo[1,3]dioxol-5-yl-3-benzyloxycarbonylamino-2-oxo-2,3-dihydro-benzo[e][1,4]diazepin-1-yl)-ethyl ester
    参考文献:
    名称:
    High affinity, bioavailable 3-Amino-1,4-benzodiazepine-Based γ-Secretase inhibitors
    摘要:
    In this paper, we describe the development of a novel series of high affinity, orally bioavailable 3-amino-1,4 benzodiazepine-based gamma-secretase inhibitors for the potential treatment of Alzheimer's disease. We disclose structure-activity relationships based around the 1, 3 and 5 positions of the benzodiazepine core structure. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2003.07.031
点击查看最新优质反应信息